Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
The following section summarizes insights on Adcock Ingram Holdings Limited's Net Income to Common Excl Extra Items:
We've identified the following companies as similar to Adcock Ingram Holdings Limited because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Net Income to Common Excl Extra Items |
|---|---|---|
| Teva Pharmaceutical Industries Ltd | TASE:TEVA | -5.961 B |
| Viatris Inc | WBAG:VTRS | -612.2 M |
| Bausch Health Companies Inc | TSX:BHC | -66.134 M |
| Healthcare | SECTOR:HLTH.ZA | 40.252 M |
| Ascendis Health Ltd | JSE:ASC | 41.569 M |
| Hikma Pharmaceuticals PLC | LSE:HIK | 286.7 M |
| Adcock Ingram Holdings Limited | JSE:AIP | 759.5 M |
| HALEON PLC | LSE:HLN | 1.442 B |
| Aspen Pharmacare Holdings Ltd | JSE:APN | 4.478 B |
| Endo Inc. | OTCPK:NDOI | 5.46 B |
| Gedeon Richter PLC | BUSE:RICHTER | 239.2 B |
| Pfizer Inc | BVC:PFE | 35,330.5 B |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Net Income to Common Excl Extra Items in the popular category include:
Represents the net income or loss available to common stockholders and is arrived after adjusting preferred stock dividends and other adjustments to n...
Adcock Ingram reported net income to common excl extra items of 759.5 M for the latest twelve months ending December 31, 2024 on its income statement.
The tables below summarizes Adcock Ingram’s Net Income to Common Excl Extra Items and common size over the last five years:
| Fiscal Year | Net Income to Common Excl Extra Items | Revenue | % Revenue |
|---|---|---|---|
| 2020-06-30 | 676.4 M | 7.347 B | 9.2% |
| 2021-06-30 | 657.5 M | 7.777 B | 8.5% |
| 2022-06-30 | 800.3 M | 8.706 B | 9.2% |
| 2023-06-30 | 898.4 M | 9.132 B | 9.8% |
| 2024-06-30 | 814 M | 9.643 B | 8.4% |
The tables below summarizes Adcock Ingram’s Net Income to Common Excl Extra Items and common size over the last four quarters:
| Quarter Ending | Net Income to Common Excl Extra Items | Revenue | % Revenue |
|---|---|---|---|
| 2024-03-31 | 184.9 M | 2.451 B | 7.5% |
| 2024-06-30 | 184.9 M | 2.451 B | 7.5% |
| 2024-09-30 | 194.9 M | 2.357 B | 8.3% |
| 2024-12-31 | 194.9 M | 2.357 B | 8.3% |
The chart above depicts the distribution of Net Income to Common Excl Extra Items for companies operating in the Healthcare Sector in the Developing economic region. Over 1,195 companies were considered in this analysis, and 1,152 had meaningful values. The average Net Income to Common Excl Extra Items of companies in the Sector is 391.2 M with a standard deviation of 1.118 B. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
Adcock Ingram Holdings Limited's Net Income to Common Excl Extra Items of 759.5 M ranks in the 82.0% percentile for the Sector. The following table provides additional summary stats:
| Economic Risk Region | Developing |
| Total Constituents | 1,200 |
| Included Constituents | 1,152 |
| Min | -1.815 B |
| Max | 8.365 B |
| Median | 76.833 M |
| Mean | 391.2 M |
| Standard Deviation | 1.118 B |
You can find companies with similar Net Income to Common Excl Extra Items using this stock screener.